Severe childhood atopic dermatitis

##plugins.themes.academic_pro.article.main##

Anis Mahfoudh
Inès Zaraa
Thouraya Amara
Hela Zribi
Dalenda El Euch
Mourad Mokni
Amel Ben Osman

Abstract

Background: Atopic dermatitis (AD) is a chronic relapsing eczematous skin disease. It represents one of the symptoms of atopic diathesis. DA affects usually infants and children.
aim : The aim of our study is to draw up the epidemiological, clinical features, treatment and outcome of severe childhood AD through a hospital series.
methods: A retrospective study of 24 cases of severe childhood AD hospitalized in the Dermatology Department of La Rabta hospital of Tunis was conducted during a 28 year-period (1981 – 2009).
results: The hospital incidence of severe childhood AD was 0,085‰. Patient’s mean age at the beginning was 14 months. The sex ratio H/F was 1.66. Cutaneous manifestations occurred preferentially in face (75%). Generalized eczema was observed in 37.5% of cases. Pruritus and xerosis were constant. The mean duration of hospitalization was 11 days. Topical corticosteroids was the most effective method of treating severe DA, associated with antiseptic solutions emollient and antihistaminic drugs. Infectious complications were noted in 50% of cases. Ocular complications were observed in 16.7% of cases. Recurrences were reported in 9 cases.
Conclusion :AD is an inflammatory, chronically relapsing, and pruritic skin disorder developing in a xerotic skin. Severe AD in childhood is rare in Tunisia. It requires a good understanding of therapeutic modalities by the patient and his family. It is a cause of important morbidity and it may have a bad impact on quality of life.

Keywords:

Atopic dermatitis, child, eczema, severe

##plugins.themes.academic_pro.article.details##

References

  1. Hanifin JM, Rajka G. Diagnoses features of atopic dermatitis. Acta Derm Venerol 1980; 92: 44-7
  2. Williams HC, Burney PG, Strachan D, Hay RJ et al. The UK Working party's diagnosis criteria for atopic dermatitis; Br J Dermatol 1994; 131: 383-96
  3. Kunz B., Oranje A.P., Labreze L., Stalder J.F., Ring J., Taied A.Clinical validation and guidelines for the SCORAD index : consensus report of the European Task Force on Atopic Dermatitis. 1997 - Dermatology 195: 10-9
  4. Pruszkowski A, Revuz J. Dermatite atopique. Données épidémiologiques actuelles. Le Concours Médical 2000; 122:1109-13
  5. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general popoulation. J Am Acad Dermatol 1994; 30:35-9
  6. Eleuch N, Turki H, Marrakchi F, Bouassida S et al. La dermatite atopique (prévalence et manifestations cliniques). Ann Dermatol Vénérol 1999; 126: 54
  7. Kharfi M, Bel Hadj Ali H, Khaled A et al. Dermatite atopique en Tunisie : Aspects épidémiologique et clinique. Ann Dermatol Venerol 2001, 128: 623-5
  8. Meneghini CL, Bonifazi E. Correlation between clinical and immunological findings in atopic dermatitis. Acta Derm Venerol 1985; 114: 140-2
  9. Schimied C, Saurat JH. Epidémiologie de la dermatite atopique. Ann Dermatol Venerol 1989; 116: 729-34
  10. Diepegen TL, Blettner N. Analyses of familial aggregation of atopic eczema and other atopic diseases by odds ratio regression models. J Invest Dermatol 1996; 106: 977-81
  11. Conférence de consensus: Prise en charge de la dermatite atopique de l'enfant. Ann Dermatol Venerol 2005; 132: 81-91
  12. De Prost Y. Dermatite atopique. Diagnostic, évolution, traitement. Rev Prat 1994; 44:807
  13. Czech W, Stalder BM, Schopf E, Kapp A. Ig E antibodies in atopic dermatitis. Allergy 1995; 50: 243-8.
  14. Bodmere C. La dermatite atopique. Allergologie pédiatrique. 2007; 22:184-93.
  15. Lucky AW et al. Use of an emollient as a steroid: sparing agent dermatitis in children. Pediatr Dermatol 1997; 14: 321-4.
  16. Baker BS. The role of microorganisms in atopic dermatitis. Clin Exp Immunol 2006; 144: 1-9.
  17. Williams HC, Strachan DP. The natural history of childhood eczema. Br J Dermatol 1998; 139: 834-39.